Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Targets, Volume 21 - Number 11



Review Article

A Review of Aberrant DNA Methylation and Epigenetic Agents Targeting DNA Methyltransferases in Endometriosis

, 21(11): 1047 - 1055

Leilei Ding, Li Yang*, Chenchen Ren*, Huawen Zhang, Jie Lu, Senyan Wang, Zimeng Wu and Yanan Yang


DOI: 10.2174/1389450121666200228112344



Review Article

N6-methyladenine RNA Modification (m6A): An Emerging Regulator of Metabolic Diseases

, 21(11): 1056 - 1067

Hui Zhong, Hui-Fang Tang and Yin Kai*


DOI: 10.2174/1389450121666200210125247




Review Article

Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy

, 21(11): 1084 - 1098

Fengqian Chen, Yunzhen Shi, Jinming Zhang and Qi Liu*


DOI: 10.2174/1389450121666200514222900



Review Article

The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer

, 21(11): 1099 - 1104

Linqi Yang, Wenqi Zhang, Saiyam Chopra, Deeepjyot Kaur, Huibing Wang, Meng Li, Pingping Chen* and Wei Zhang*


DOI: 10.2174/1389450121666200504080112



General Review Article

An Insight into the Current Perspective and Potential Drug Targets for Visceral Leishmaniasis (VL)

, 21(11): 1105 - 1129

Rani Mansuri*, Jagbir Singh and Anupama Diwan


DOI: 10.2174/1389450121666200422083735



General Review Article

Current and Future Prospective of a Versatile Moiety: Imidazole

, 21(11): 1130 - 1155

Nidhi Rani*, Praveen Kumar, Randhir Singh, Damião P. de Sousa and Prerna Sharma


DOI: 10.2174/1389450121666200530203247




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63

Advertisement

PLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog